Mathematical Models for Neglected Tropical Diseases: Essential Tools for Control and Elimination, Part B

Chapter One. Mathematical Modelling of Trachoma Transmission, Control and Elimination

• 1. Introduction
• 2. Methods
• 3. Results
• 4. Discussion

Chapter Two. Progress in the Mathematical Modelling of Visceral Leishmaniasis

• 1. Introduction
• 2. Mathematical Models of Visceral Leishmaniasis
• 3. Data–Model Interactions
• 4. Modelling Interventions
• 5. Conclusions

Chapter Three. Soil-Transmitted Helminths: Mathematical Models of Transmission, the Impact of Mass Drug Administration and Transmission Elimination Criteria

• 1. Introduction
• 2. Key Epidemiological Features and Processes
• 3. Mathematical Models
• 4. Conclusions

Chapter Four. Studies of the Transmission Dynamics, Mathematical Model Development and the Control of Schistosome Parasites by Mass Drug Administration in Human Communities

• 1. Introduction
• 2. Epidemiological Patterns
• 3. Population Processes
• 4. Mathematical Models of the Basic Dynamics of Transmission
• 5. Parameter Estimation
• 6. Numerical Studies of Mass Drug Administration Programmes
• 7. Stochastic Models – The Questions of Elimination and Eradication
• 8. Model Validation
• 9. Discussion

Chapter Five. River Blindness: Mathematical Models for Control and Elimination

• 1. Introduction
• 2. The Models
• 3. Model Validation
• 4. Modelling Current Treatment Strategies
• 5. Modelling Alternative Intervention Strategies
• 6. Economic Evaluations
• 7. Challenges and Future Directions
• 8. Conclusions

Chapter Six. The Role of More Sensitive Helminth Diagnostics in Mass Drug Administration Campaigns: Elimination and Health Impacts

• 1. Introduction
• 2. Modelling Diagnostics
• 3. Modelling Transmission Dynamics
• 4. Results
• 5. Discussion

Chapter Seven. Lessons Learned From Developing an Eradication Investment Case for Lymphatic Filariasis

• 1. Introduction
• 2. The Current State of (Efforts Against) Lymphatic Filariasis
• 3. The Feasibility of Eliminating and Eradicating Lymphatic Filariasis
• 4. Evidence for Informing Investment Decisions for Lymphatic Filariasis Elimination and Eradication
• 5. Interpretation, Limitations, and Priorities for Further Research
• 6. Conclusions

Index

Contents of Volumes in This Series

• Volume 41
• Volume 42
• Volume 43
• Volume 44
• Volume 45
• Volume 46
• Volume 47
• Volume 48
• Volume 49
• Volume 50
• Volume 51
• Volume 52
• Volume 53
• Volume 54
• Volume 55
• Volume 56
• Volume 57
• Volume 58
• Volume 59
• Volume 60
• Volume 61
• Volume 62
• Volume 63
• Volume 64
• Volume 65
• Volume 66
• Volume 67
• Volume 68
• Volume 69
• Volume 70
• Volume 71
• Volume 72
• Volume 73
• Volume 74
• Volume 75
• Volume 76
• Volume 77
• Volume 78
• Volume 79
• Volume 80
• Volume 81
• Volume 82
• Volume 83
• Volume 84
• Volume 85
• Volume 86
• Volume 87
• Volume 88
• Volume 89
• Volume 90
• Volume 91
• Volume 92
• Volume 93